Fig. 4From: Immunogenicity of biologic therapies for migraine: a review of current evidenceAnti-drug antibodies and neutralizing antibodies in fremanezumab trials [2, 39,40,41,42]. EM, episodic migraine; CM, chronic migraine; LTS, long-term studyBack to article page
